Bacitracin Zinc eent
Name: Bacitracin Zinc eent
Bacitracin Zinc Pharmacokinetics
Absorption
Extent
Not substantially absorbed from intact or denuded skin, wounds, or mucous membranes.a
Distribution
Extent
Not known whether topical bacitracin is distributed into breast milk.e g
Stability
Storage
Ophthalmic
OintmentBacitracin: 15–30°C.a
Bacitracin zinc and polymyxin B sulfate: 20–25°C.d
Neomycin and polymyxin B sulfates and bacitracin zinc: 20–25°C.e
Neomycin and polymyxin B sulfates and bacitracin zinc with hydrocortisone: 15–30°C.f
Neomycin and polymyxin B sulfates and bacitracin zinc with hydrocortisone acetate: 15–25°C.104
Advice to Patients
-
Importance of not touching tip of container to the eye, eyelid, fingers, or any other surface to avoid contamination.101 104 e f Advise patient to keep container tightly closed when not in use.e f
-
Importance of discontinuing therapy and contacting clinician if the infection worsens or does not improve, or if any signs of sensitivity occur (e.g., rash, itching, swelling, redness, burning).101 104 a e f
-
Advise patient not to share the drug with any other person.104 e
-
Importance of informing clinician of existing or contemplated concomitant therapy, including prescription and OTC drugs as well as any concomitant illnesses.104 d e
-
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.104 e
-
Importance of informing patients of other important precautionary information. (See Cautions.)
Preparations
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Please refer to the ASHP Drug Shortages Resource Center for information on shortages of one or more of these preparations.
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Ophthalmic | Ointment | 500 units/g* | Bacitracin | Akorn, Fougera |
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Ophthalmic | Ointment | Bacitracin Zinc 500 units (of bacitracin) per g and Polymyxin B Sulfate 10,000 units (of polymyxin B) per g | AK-Poly-Bac | Akorn |
Bacitracin Zinc and Polymyxin B Sulfate | Bausch & Lomb, Fougera |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Ophthalmic | Ointment | Neomycin Sulfate 0.35% (of neomycin), Polymyxin B Sulfate 10,000 units (of polymyxin B) per g, and Bacitracin Zinc 400 units (of bacitracin) per g* | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | Bausch & Lomb, Fougera |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Ophthalmic | Ointment | Neomycin Sulfate 0.35% (of neomycin), Polymyxin B Sulfate 10,000 units (of polymyxin B) per g, and Bacitracin Zinc 400 units (of bacitracin) per g, and Hydrocortisone 1%* | Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone | Bausch & Lomb |
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Ophthalmic | Ointment | Neomycin Sulfate 0.35% (of neomycin), Polymyxin B Sulfate 10,000 units (of polymyxin B) per g, Bacitracin Zinc 400 units (of bacitracin) per g, and Hydrocortisone Acetate 1% | Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone Acetate | Fougera |